Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

MELODY Study Group

doi:10.1056/NEJMc2214773

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

MELODY Study Group

Paediatrics

Research output: Contribution to journal › Letter › peer-review

123 Citations (Scopus)

Original language	English
Pages (from-to)	1533-1534
Number of pages	2
Journal	The New England Journal of Medicine
Volume	388
Issue number	16
DOIs	https://doi.org/10.1056/NEJMc2214773
Publication status	Published - 20 Apr 2023

Access to Document

10.1056/NEJMc2214773

Cite this

@article{4a259ae72b9345ffade81a4c20088fc7,

title = "Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants",

keywords = "Humans, Infant, Infant, Newborn, Antibodies, Monoclonal, Humanized/therapeutic use, Antiviral Agents/therapeutic use, Hospitalization, Infant, Premature, Palivizumab, Respiratory Syncytial Virus Infections/prevention & control, Term Birth, Infant, Newborn, Diseases/drug therapy",

author = "{MELODY Study Group} and Muller, {William J} and Madhi, {Shabir A} and {Seoane Nu{\~n}ez}, Beatriz and {Baca Cots}, Manuel and Miroslava Bosheva and Ron Dagan and Hammitt, {Laura L} and Llapur, {Conrado J} and Novoa, {Jose M} and {Saez Llorens}, Xavier and Amy Grenham and Kelly, {Elizabeth J} and Mankad, {Vaishali S} and Manish Shroff and Therese Takas and Amanda Leach and Tonya Villafana and Peter Richmond",

year = "2023",

month = apr,

day = "20",

doi = "10.1056/NEJMc2214773",

language = "English",

volume = "388",

pages = "1533--1534",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOC",

number = "16",

}

TY - JOUR

T1 - Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

AU - MELODY Study Group

AU - Muller, William J

AU - Madhi, Shabir A

AU - Seoane Nuñez, Beatriz

AU - Baca Cots, Manuel

AU - Bosheva, Miroslava

AU - Dagan, Ron

AU - Hammitt, Laura L

AU - Llapur, Conrado J

AU - Novoa, Jose M

AU - Saez Llorens, Xavier

AU - Grenham, Amy

AU - Kelly, Elizabeth J

AU - Mankad, Vaishali S

AU - Shroff, Manish

AU - Takas, Therese

AU - Leach, Amanda

AU - Villafana, Tonya

AU - Richmond, Peter

PY - 2023/4/20

Y1 - 2023/4/20

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Antibodies, Monoclonal, Humanized/therapeutic use

KW - Antiviral Agents/therapeutic use

KW - Hospitalization

KW - Infant, Premature

KW - Palivizumab

KW - Respiratory Syncytial Virus Infections/prevention & control

KW - Term Birth

KW - Infant, Newborn, Diseases/drug therapy

UR - https://www.nejm.org/doi/10.1056/NEJMc2214773

U2 - 10.1056/NEJMc2214773

DO - 10.1056/NEJMc2214773

M3 - Letter

C2 - 37018470

SN - 0028-4793

VL - 388

SP - 1533

EP - 1534

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 16

ER -

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

Access to Document

Other files and links

Cite this